Standardized fluorescence in situ hybridization testing based on an appropriate panel of probes more effectively identifies common cytogenetic abnormalities in myelodysplastic syndromes than conventional cytogenetic analysis: A multicenter prospective study of 2302 patients in China
Yue‐Yun Lai, Xiao‐Jun Huang, Juan Li, Ping Zou, Zefeng Xu, Hui Sun, Zonghong Shao, Daobin Zhou, Fangping Chen, Zhuogang Liu, Huanling Zhu, Depei Wu, Chun Wang, Yin Zhang, Yan Li, Ming Hou, Xin Du, Xin Wang, Wei Li, Yong-Rong Lai, Jin Zhou, Yuhong Zhou, Meiyun Fang, Lin Qiu, Xiaomin Wang, Guangsen Zhang, Ming Jiang, Yingmin Liang, Liansheng Zhang, Xiequn Chen, Hai Bai, Jin-Ying Lin
Abstract